MarginsXMarginsX
Home › Data Desk › Going concern this week: filings, movers and insider trades to Nov 13, 2026

MarginsX Data Desk · Weekly roundups · Going-concern doubt

Going concern this week: filings, movers and insider trades to Nov 13, 2026

We track 553 companies in our small-cap universe whose filings center on going concern. (MarginsX topic index of company filings, Nov 13, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 14, 2026.

Abstract illustration: one large circle splitting into many smaller circles drifting apart.

Movers

Focus Universal Inc. (FCUV) rose 148.8% over the week to Nov 13, 2026, closing at $7.08. (Daily closes (Yahoo Finance chart endpoint), Nov 13, 2026)

Dixie Group Inc (DXYN) rose 80.0% over the week to Nov 13, 2026, closing at $0.630. (Daily closes (Yahoo Finance chart endpoint), Nov 13, 2026)

Semnur Pharmaceuticals, Inc. (SMNR) rose 56.7% over the week to Nov 13, 2026, closing at $0.470. (Daily closes (Yahoo Finance chart endpoint), Nov 13, 2026)

Hartford Creative Group, Inc. (HFUS) rose 50.0% over the week to Nov 13, 2026, closing at $3.00. (Daily closes (Yahoo Finance chart endpoint), Nov 13, 2026)

Modular Medical Inc. (MODD) rose 48.1% over the week to Nov 13, 2026, closing at $1.97. (Daily closes (Yahoo Finance chart endpoint), Nov 13, 2026)

From the desk this week

Amesite Inc. gets a listing-standard notice from its exchange (MarginsX Data Desk article, Nov 14, 2026)

QumulusAI Inc. grows revenue 375.9% in the quarter to Sep 30, 2026 (MarginsX Data Desk article, Nov 13, 2026)

Nika Pharmaceuticals, Inc reports $352 of cash, about 0.1 months at its recent burn (MarginsX Data Desk article, Nov 13, 2026)

Exchange notice: Launch One Acquisition Corp. falls short of a listing standard (MarginsX Data Desk article, Nov 13, 2026)

New auditor filing at CXJ GROUP CO., Ltd (MarginsX Data Desk article, Nov 14, 2026)

Late 10-Q notice from RetinalGenix Technologies Inc. (MarginsX Data Desk article, Nov 14, 2026)

Insider purchases

Coastlands Capital LP bought 50,000 shares of Bolt Biotherapeutics Inc. at $6.38 on Nov 9, 2026, worth $319K. (SEC EDGAR, Form 4, Nov 10, 2026)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
Topic titleGoing concernSource2026-11-13
Week endNov 13, 2026Source2026-11-13
Companies553Source2026-11-13
Topicgoing concernSource2026-11-13
NameFocus Universal Inc.Source2026-11-13
SymbolFCUVSource2026-11-13
Week change1.488 %Source2026-11-06
Close7.08 USDSource2026-11-13
Close2.846 USDSource2026-11-06
NameDixie Group IncSource2026-11-13
SymbolDXYNSource2026-11-13
Week change0.8 %Source2026-11-06
Close0.63 USDSource2026-11-13
Close0.35 USDSource2026-11-06
NameSemnur Pharmaceuticals, Inc.Source2026-11-13
SymbolSMNRSource2026-11-13
Week change0.567 %Source2026-11-06
Close0.47 USDSource2026-11-13
Close0.3 USDSource2026-11-06
NameHartford Creative Group, Inc.Source2026-11-13
SymbolHFUSSource2026-11-13
Week change0.5 %Source2026-11-06
Close3 USDSource2026-11-13
Close2 USDSource2026-11-06
NameModular Medical Inc.Source2026-11-13
SymbolMODDSource2026-11-13
Week change0.481 %Source2026-11-06
Close1.97 USDSource2026-11-13
Close1.33 USDSource2026-11-06
InsiderCoastlands Capital LPSource2026-11-10
Shares50,000 sharesSource2026-11-10
NameBolt Biotherapeutics Inc.Source2026-11-13
Avg price6.38 USDSource2026-11-10
Trade dateNov 9, 2026Source2026-11-10
Value319,000 USDSource2026-11-10

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS